arrow_back Trending Legislation
Share share

Opioid Addiction Treatment: Telehealth Prescribing for Controlled Substances.

The TREATS Act aims to increase access to opioid use disorder treatment by allowing practitioners to prescribe certain controlled substances (Schedules III, IV, or V) approved by the FDA after only one telehealth evaluation. This change removes the mandatory initial in-person visit for these specific medications, making it easier for patients, especially those in remote areas, to start treatment quickly. The goal is to leverage telemedicine to combat the opioid crisis.
Key points
Allows prescribing of FDA-approved controlled substances (Schedules III, IV, or V, excluding methadone) for opioid use disorder treatment following a single telehealth evaluation.
Removes the requirement for an initial in-person medical evaluation for prescribing these specific addiction treatment medications.
Defines 'telehealth evaluation' as a real-time, two-way interactive communication (audio-only or audio and video) conducted remotely by a practitioner.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Telehealth Response for E-prescribing Addiction Therapy Services Act
Print number: HR 5163
Sponsor: Rep. Trone, David J. [D-MD-6]
Process start date: 2023-08-04
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Opioid Addiction Treatment: Telehealth Prescribing for Controlled Substances.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 5163.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-08-04.

What are the main provisions?

Key points include:

  • Allows prescribing of FDA-approved controlled substances (Schedules III, IV, or V, excluding methadone) for opioid use disorder treatment following a single telehealth evaluation.
  • Removes the requirement for an initial in-person medical evaluation for prescribing these specific addiction treatment medications.
  • Defines 'telehealth evaluation' as a real-time, two-way interactive communication (audio-only or audio and video) conducted remotely by a practitioner.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Trone, David J. [D-MD-6].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Analysis and Potential Impact of HR 5163

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health